U.S. regulators will vote this week on whether the contraceptive Opill should be made widely available without a prescription.
U.S. health regulators are considering whether a decades-old birth control pill should be made just as available as drugs like Tylenol and Ibuprofen.
The agency also brought up Opill's labeling, saying younger teenagers may have difficulties understanding and correctly following its directions."The study findings suggest that consumers do not adequately understand some of the necessary actions they need to take if they miss a tablet in order to avoid unintended pregnancy," reviewers wrote.
"The results of this study appear to indicate that most females with current or previous breast cancer would appropriately deselect from taking norgestrel tablets," the agency said."However, the results also show that there are some females with current or previous breast cancer who would — in the absence of a healthcare intermediary — incorrectly consider it"appropriate to use" for themselves.
While the most common use of oral contraceptives, like Opill, is to prevent pregnancy, many women also use them to manage other medical conditions — such as irregular menstruation, menstrual pain, and acne.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
FDA weighing first over-the-counter birth control pillOn Friday, the Food and Drug Administration posted its initial review of a decades-old pill that could become the first drug of its kind to move over the counter.
Les mer »
Some Pilot COVID-19 At Home Tests recalled by FDA over bacteria risk | CNNThe US Food and Drug Administration issued a warning on Friday to consumers and health providers to discontinue using and discard recalled Pilot COVID-19 At-Home Tests made by SD Biosensor, Inc. over 'significant concerns' of bacterial contamination.
Les mer »
Samsung gets FDA clearance for irregular heart rhythm notificationsBut you’ll have to wait until One UI 5 Watch arrives later this year.
Les mer »
Immuron stock rockets after FDA removes hold on IND of infectious diarrhea treatmentThe U.S.-listed shares of Immuron Ltd. powered up 66.3% toward a one-year high in premarket trading Monday, after the Australia-based biopharmaceutical...
Les mer »
Abortion pill legal challenge threatens miscarriage careA million U.S. women a year suffer miscarriages, which occur in at least 15% of known pregnancies. Mifepristone was approved in 2000 for early abortions but it is often used “off label” to treat early pregnancy loss or to speed up delivery when a fetus dies later in pregnancy. These uses are so common that U.S. senators urged manufacturer Danco to apply to the FDA to add miscarriage to the label of its drug, Mifeprex.
Les mer »
FDA weighing first over-the-counter birth control pillOn Friday, the Food and Drug Administration posted its initial review of a decades-old pill that could become the first drug of its kind to move over the counter.
Les mer »